Jim Cramer discusses Kura Oncology as a speculative bet
I'm PortAI, I can summarize articles.
Jim Cramer discussed Kura Oncology (NASDAQ:KURA) as a speculative investment. He noted the company's $135 million milestone payment from the U.S. commercial sale of KOMZIFTI, emphasizing that these are milestone payments, not actual earnings.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments